Linifanib and its Impurities

Linifanib orally bioavailable, small-molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Reference standards of Linifanib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.